SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending downwards as investors react to earnings results and future outlook, with concerns focused on debt and increased spending related to AI infrastructure. The community is debating whether the company's AI investments will translate to profits, with some expressing skepticism about the current valuation. Others believe the selloff is an overreaction and a buying opportunity, pointing to Oracle's backlog and potential for long-term growth.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending downwards as the community discusses its potential acquisition of Warner Bros. Discovery and the impact of increased debt. Some traders believe the stock is oversold and poised for a bounce, while others anticipate further declines depending on the outcome of the bidding war with Paramount and potential regulatory hurdles.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

MSFT is trending amid mixed sentiment, with some traders expressing frustration over its recent performance relative to the broader market and other tech stocks; many believe the stock is being manipulated. Despite the negative sentiment, there's optimism regarding Microsoft's AI initiatives and potential upside, with analysts reiterating buy ratings and high price targets.

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

Mawson Infrastructure Group ($MIGI) is trending due to sector-wide strength in Bitcoin mining stocks and speculation around its expanding digital infrastructure, including AI/GPU hosting. The community is discussing the stock's low float, potential for a short squeeze, and anticipation of catalysts from an upcoming Emerging Growth Conference. Some traders are setting aggressive price targets, citing the company's infrastructure buildout and potential for new contracts.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as traders discuss its bullish chart structure and potential breakout, fueled by strong buying momentum. Community members are highlighting confidence in the stock's trend and anticipating further upward movement. Some traders point to the company's need for cash and recent news including an acquisition that could affect the company.

Beasley Broadcast Group, Inc. is multi-platform media company, which engages in the operation of radio stations in the United States. The firm offers marketing solutions across event platforms. It operates through the following business segments: Audio, Digital, and Other. The company was founded by George G. Beasley in 1961 and is headquartered in Naples, FL.

Beasley Broadcast Group Inc - Ordinary Shares - Class A

BBGI is trending due to its high volatility and potential for sharp scalps, though a confirmed catalyst remains unclear. Community discussions revolve around whether it can repeat the massive gains seen earlier in the day, or if it is set to fade, drawing comparisons to similar volatile runners like $SMX. Traders are actively debating strategies around potential overnight moves and short positions.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana's stock is trending amid discussions about its upcoming inclusion in the S&P 500, with some traders anticipating a continued rise while others foresee a sell-the-news event. Community members are debating the company's valuation, debt, and potential risks, with a segment highlighting possible fraud and regulatory concerns. Bullish sentiment is fueled by the S&P 500 inclusion, while bears point to the high P/E ratio and subprime loan book.

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals is trending due to increased momentum in low-float biotech stocks, with traders actively discussing its potential for a significant price surge. The community is also highlighting the company's phase 3 trial and analyzing the stock's chart patterns, while noting the company's small market cap relative to the potential market for its lead drug candidate.

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

Enveric Biosciences ($ENVB) is trending following a patent allowance for its EVM301 series, sparking discussion about the potential of its neuroplasticity drug platform. The community is focused on the stock's low float and potential for a short squeeze, while also considering the company's history of dilution. Some traders are speculating about a potential settlement with AbbVie related to intellectual property.

The Kraft Heinz Co. engages in the manufacture and market of food and beverage products. It operates through the North America and International geographical segments. The company was founded on July 2, 2015, and is headquartered in Pittsburgh, PA.

Kraft Heinz Co

Kraft Heinz is trending as investors discuss its value, dividend yield, and potential as a recession-resistant stock, with some eyeing it as a turnaround speculation. Community discussions include options trading strategies and speculation around potential catalysts, like an acquisition or company split, despite concerns about debt and Buffett's disappointment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fresenius Medical Names Charles Hugh-Jones Global CMO

(RTTNews) - Fresenius Medical Care AG (FMS, FME.DE), a provider of dialysis products and services, on Wednesday announced that it has appointed Charles Hugh-Jones as Global Chief Medical Officer on...

Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical...

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Upgraded at Wall Street Zen

Wall Street Zen upgraded Fresenius Medical Care AG & Co. KGaA from a "buy" rating to a "strong-buy" rating in a research report on Friday...

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives Average Rating of "Reduce" from Brokerages

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) has been given a consensus recommendation of "Reduce" by the six research firms that are currently covering the firm, MarketBeat...

Here's Why Fresenius (FMS) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

ABC Arbitrage SA Has $6.55 Million Holdings in Fresenius Medical Care AG & Co. KGaA $FMS

ABC Arbitrage SA increased its position in shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Free Report) by 18.2% during the second quarter, according to the company in its most recent...

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Rating Lowered to Buy at Wall Street Zen

Wall Street Zen cut shares of Fresenius Medical Care AG & Co. KGaA from a "strong-buy" rating to a "buy" rating in a research report on Saturday...

Zacks Research Downgrades Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to Hold

Zacks Research downgraded Fresenius Medical Care AG & Co. KGaA from a "strong-buy" rating to a "hold" rating in a research report on Tuesday...

Fresenius Medical Care AG & Co. KGaA $FMS Shares Purchased by Assetmark Inc.

Assetmark Inc. grew its holdings in shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Free Report) by 248.6% in the 2nd quarter, according to the company in its most recent disclosure with...

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

FMS
Fresenius Medical Care AG & Co. KGAA

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest FMS News

FMSFresenius Medical Care AG & Co. KGAA